Assembly Biosciences (ASMB) Cash from Investing Activities (2011 - 2026)

Assembly Biosciences' Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$5.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 181.72% year-over-year to -$5.4 million; the TTM figure through Mar 2026 stood at -$125.4 million (down 525.42% YoY), while the FY2025 annual figure was -$113.5 million, down 382.46% from the prior year.
• Cash from Investing Activities was -$5.4 million for Q1 2026 at Assembly Biosciences, down from $21.2 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $33.0 million in Q1 2022 to a low of -$158.3 million in Q3 2025.
• Historically, Cash from Investing Activities has averaged -$3.4 million across 5 years, with a median of $10.0 million in 2023.
• Biggest YoY gain for Cash from Investing Activities was 416.95% in 2025; the steepest drop was 746.32% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at $16.6 million in 2022, then sank by 641.32% to -$89.7 million in 2023, then soared by 92.53% to -$6.7 million in 2024, then jumped by 416.95% to $21.2 million in 2025, then tumbled by 125.36% to -$5.4 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.4 million (Q1 2026), $21.2 million (Q4 2025), and -$158.3 million (Q3 2025), per Business Quant data.